Skip to main content

News Releases & Statements

News Releases & Statements

James

James Davis, Biotechnology Consultant, Elected Chair of LLS National Board of Directors

For Immediate Release

Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
andrea.greif@lls.org

Read More
Burlington

Burlington and The Leukemia & Lymphoma Society: Saving Lives is Always in Style

White Plains, NY (July 14, 2014) - Burlington and The Leukemia & Lymphoma Society's (LLS) Light The Night® Walk fundraising campaign have partnered once again to raise money for blood cancer research. Read More

arGEN-X

arGEN-X and LLS Partner on the Development of ARGX-10 for the Treatment of Waldenstrom's Macroglobulinemia

Breda, the Netherlands / Ghent, Belgium and White Plains, NY, USA (June 10, 2014) - arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenstrom's macroglobulinemia (WM). Read More

Harry

Harry T. Mangurian Jr. Foundation Commits $4 Million to Help Beat AML

Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
andrea.greif@lls.org


News Release

White Plains, N.Y. (May 22, 2014) - The Leukemia & Lymphoma Society (LLS) today announced a $4 million commitment by the Harry T. Mangurian, Jr. Foundation to support a groundbreaking collaboration between LLS and with Brian Druker, M.D., of Oregon Health and Science University to "Beat AML."

Read More
Francie

Francie Heller, Managing Partner at Heller Advisory, Elected to The Leukemia & Lymphoma Society National Board of Directors

Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
andrea.greif@lls.org


News Release

White Plains, N.Y. (May 15, 2014) - Francie Heller, managing partner at Heller Advisory, has been elected to the national board of directors of The Leukemia & Lymphoma Society (LLS), effective July 1, 2014.  Her term will run through June 30, 2017.

Read More
William

William S. Dalton, Founder and CEO of M2Gen, Elected to The Leukemia & Lymphoma Society National Board of Directors

Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
andrea.greif@lls.org

 

News Release

William S. Dalton, Founder and CEO of M2Gen, Elected to The Leukemia & Lymphoma Society National Board of Directors 

Read More

Media Requests

Please send all media-related inquiries and interview requests to mediarelations@lls.org.  An LLS representative will respond as soon as possible.